5,7,4'-Trihydroxy-3,8-dimethoxyflavone

Details

Top
Internal ID 13142b87-d816-43ac-a7ee-bd4e560b0f0b
Taxonomy Phenylpropanoids and polyketides > Flavonoids > O-methylated flavonoids > 8-O-methylated flavonoids
IUPAC Name 5,7-dihydroxy-2-(4-hydroxyphenyl)-3,8-dimethoxychromen-4-one
SMILES (Canonical) COC1=C(C=C(C2=C1OC(=C(C2=O)OC)C3=CC=C(C=C3)O)O)O
SMILES (Isomeric) COC1=C(C=C(C2=C1OC(=C(C2=O)OC)C3=CC=C(C=C3)O)O)O
InChI InChI=1S/C17H14O7/c1-22-15-11(20)7-10(19)12-13(21)17(23-2)14(24-16(12)15)8-3-5-9(18)6-4-8/h3-7,18-20H,1-2H3
InChI Key QEXFTGWTWYZALN-UHFFFAOYSA-N
Popularity 6 references in papers

Physical and Chemical Properties

Top
Molecular Formula C17H14O7
Molecular Weight 330.29 g/mol
Exact Mass 330.07395278 g/mol
Topological Polar Surface Area (TPSA) 105.00 Ų
XlogP 2.80
Atomic LogP (AlogP) 2.59
H-Bond Acceptor 7
H-Bond Donor 3
Rotatable Bonds 3

Synonyms

Top
5,7,4'-Trihydroxy-3,8-dimethoxyflavone
Herbacetin 3,8-dimethyl ether
LMPK12113156
3,8-Dimethoxy-4',5,7-trihydroxyflavone

2D Structure

Top
2D Structure of 5,7,4'-Trihydroxy-3,8-dimethoxyflavone

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9440 94.40%
Caco-2 + 0.7258 72.58%
Blood Brain Barrier - 0.7750 77.50%
Human oral bioavailability - 0.5714 57.14%
Subcellular localzation Mitochondria 0.6642 66.42%
OATP2B1 inhibitior - 0.5608 56.08%
OATP1B1 inhibitior + 0.9179 91.79%
OATP1B3 inhibitior + 0.9261 92.61%
MATE1 inhibitior + 0.5400 54.00%
OCT2 inhibitior - 0.9750 97.50%
BSEP inhibitior - 0.4899 48.99%
P-glycoprotein inhibitior - 0.4879 48.79%
P-glycoprotein substrate - 0.8374 83.74%
CYP3A4 substrate - 0.5171 51.71%
CYP2C9 substrate - 0.6401 64.01%
CYP2D6 substrate - 0.8296 82.96%
CYP3A4 inhibition + 0.7817 78.17%
CYP2C9 inhibition + 0.6258 62.58%
CYP2C19 inhibition + 0.8187 81.87%
CYP2D6 inhibition - 0.6249 62.49%
CYP1A2 inhibition + 0.8668 86.68%
CYP2C8 inhibition + 0.6872 68.72%
CYP inhibitory promiscuity + 0.8459 84.59%
UGT catelyzed - 0.6000 60.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.6581 65.81%
Eye corrosion - 0.9779 97.79%
Eye irritation + 0.8878 88.78%
Skin irritation - 0.6522 65.22%
Skin corrosion - 0.9396 93.96%
Ames mutagenesis - 0.5000 50.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7273 72.73%
Micronuclear + 0.9200 92.00%
Hepatotoxicity + 0.5498 54.98%
skin sensitisation - 0.9222 92.22%
Respiratory toxicity - 0.5556 55.56%
Reproductive toxicity + 0.8556 85.56%
Mitochondrial toxicity + 0.6750 67.50%
Nephrotoxicity + 0.4781 47.81%
Acute Oral Toxicity (c) III 0.5920 59.20%
Estrogen receptor binding + 0.9135 91.35%
Androgen receptor binding + 0.8549 85.49%
Thyroid receptor binding + 0.5630 56.30%
Glucocorticoid receptor binding + 0.9128 91.28%
Aromatase binding + 0.7755 77.55%
PPAR gamma + 0.7749 77.49%
Honey bee toxicity - 0.8844 88.44%
Biodegradation - 0.7250 72.50%
Crustacea aquatic toxicity - 0.5300 53.00%
Fish aquatic toxicity + 0.8636 86.36%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.44% 91.11%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 94.97% 94.00%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 92.25% 94.45%
CHEMBL2581 P07339 Cathepsin D 92.21% 98.95%
CHEMBL1293249 Q13887 Kruppel-like factor 5 90.39% 86.33%
CHEMBL1806 P11388 DNA topoisomerase II alpha 90.14% 89.00%
CHEMBL1860 P10827 Thyroid hormone receptor alpha 89.34% 99.15%
CHEMBL242 Q92731 Estrogen receptor beta 88.46% 98.35%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 86.32% 95.56%
CHEMBL3401 O75469 Pregnane X receptor 85.96% 94.73%
CHEMBL3194 P02766 Transthyretin 84.14% 90.71%
CHEMBL3060 Q9Y345 Glycine transporter 2 83.82% 99.17%

Cross-Links

Top
PubChem 13983738
NPASS NPC70036
LOTUS LTS0159064
wikiData Q105219426